In recent weeks, Eli Lilly has deepened its push into AI-driven drug discovery and obesity care, including a planned US$1.00 ...

Price target rises to $275 from Jefferies. Company partners with Lilly on $1B AI drug lab. Analysts see stock trading cheap.

NVIDIA Corporation (NASDAQ:NVDA) is one of the best strong buy growth stocks to buy according to hedge funds. NVIDIA ...

Despite lacklustre dealmaking, there were still trends identified from company presentations, such as pharma's upcoming ...

The World Economic Forum's annual meeting in Davos has begun. Billionaires, CEOs, and leaders arrived in the Swiss mountain ...

The top 20 largest US public companies are investing around US$100-150 billion directly into private companies, providing ...

NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January ...

Parnassus Core Select ETF (PRCS) targets 25 high-quality large-cap stocks for long-term growth. Read the full analysis for ...

Business Insider is at the World Economic Forum in Davos, Switzerland. Follow along here for the latest updates.

Shares of Eli Lilly came under selling pressure following an announcement by the U.S. Food and Drug Administration (FDA) ...

Summary:NVIDIA’s long-term stock performance continues to fuel speculation around an NVDA stock split in 2026 The company ...

Nvidia's Stock Hasn't Been This Cheap in Over a Year. Here's What History Suggests Will Happen Next. Nvidia stock experienced ...